LFWD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LFWD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Rewalk Robotics's average Accounts Receivable for the three months ended in Dec. 2023 was $3.32 Mil. Rewalk Robotics's Revenue for the three months ended in Dec. 2023 was $6.88 Mil. Hence, Rewalk Robotics's Days Sales Outstanding for the three months ended in Dec. 2023 was 44.07.
The historical rank and industry rank for Rewalk Robotics's Days Sales Outstanding or its related term are showing as below:
During the past 12 years, Rewalk Robotics's highest Days Sales Outstanding was 199.80. The lowest was 38.82. And the median was 56.80.
Rewalk Robotics's Days Sales Outstanding increased from Dec. 2022 (31.05) to Dec. 2023 (44.07).
The historical data trend for Rewalk Robotics's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rewalk Robotics Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Sales Outstanding | Get a 7-Day Free Trial | 58.12 | 61.40 | 38.82 | 53.68 | 54.75 |
Rewalk Robotics Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 31.05 | 58.16 | 44.57 | 44.59 | 44.07 |
For the Medical Devices subindustry, Rewalk Robotics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Rewalk Robotics's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Rewalk Robotics's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Rewalk Robotics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as
Days Sales Outstanding (A: Dec. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2022 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) | / | Revenue (A: Dec. 2023 ) | * | Days in Period |
= | ( (1.036 | + | 3.12) | / | 2 ) | / | 13.854 | * | 365 |
= | 2.078 | / | 13.854 | * | 365 | ||||
= | 54.75 |
Rewalk Robotics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding (Q: Dec. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Sep. 2023 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) | / | Revenue (A: Dec. 2023 ) | * | Days in Period |
= | ( (3.529 | + | 3.12) | / | 2 ) | / | 6.884 | * | 365 / 4 |
= | 3.3245 | / | 6.884 | * | 365 / 4 | ||||
= | 44.07 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rewalk Robotics (NAS:LFWD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Rewalk Robotics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Lind Global Fund Ii Lp | 10 percent owner | 444 MADISON AVENUE, 41ST FLOOR, NEW YORK NY 10022 |
Lind Global Macro Fund Lp | 10 percent owner | 444 MADISON AVE, FLOOR 41, NEW YORK NY 10022 |
Turk Joseph E Jr | director | NXSTAGE MEDICAL INC, 439 SOUTH UNION STREET 5TH FLOOR, LAWRENCE MA 01843 |
Jeannine Lynch | officer: VP of Market Access & Strategy | C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT L3 20692203 |
Michael A Lawless | officer: Chief Financial Officer | C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203 |
Jeff Dykan | director | KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692 |
Aryeh Dan | director | KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692 |
Charles Remsberg | officer: Chief Sales Officer | C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203 |
Lawrence J Jasinski | director, officer: Chief Executive Officer | SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760 |
Randel Richner | director | C/O REWALK ROBOTICS, LTD., 3 HATNUFA ST. 6TH FL. P.O. BOX 161, YOKNEAM L3 2069203 |
Hadar Levy | director | C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203 |
Poduska John William Sr | director | 295 MEADOWBROOK RD, WESTON MA 02493 |
Yasushi Ichiki | director | KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692 |
Yohanan Engelhardt | director | 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203 |
Wayne Weisman | director | 490 LAPP ROAD, MALVERN PA 19355 |
From GuruFocus
By Marketwired • 06-30-2023
By Tiesvg Tiesvg • 12-22-2022
By GuruFocus Research GuruFocus Editor • 05-25-2023
By GlobeNewswire • 06-30-2023
By Marketwired • 07-11-2023
By sperokesalga sperokesalga • 02-16-2023
By sperokesalga sperokesalga • 05-03-2023
By Marketwired • 08-11-2023
By Marketwired • 07-28-2023
By Value_Insider Value_Insider • 11-11-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.